Aldeyra Therapeutics (ALDX) EPS (2014 - 2026)
Aldeyra Therapeutics (ALDX) EPS from Jun 30, 2014 to Mar 31, 2026. The TTM Aldeyra Therapeutics (ALDX) EPS is -$0.46. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Aldeyra Therapeutics (ALDX) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -52.97% |
| 3 Years TTM | -24.07% |
| 5 Years TTM | -15.26% |
| 10 Years TTM | -11.46% |
| All Time TTM | -9.01% |
Annual EPS change of Aldeyra Therapeutics (ALDX)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.06 | -89.83% |
| 2025 | -$0.56 | -39.91% |
| 2024 | -$0.94 | +47.65% |
| 2023 | -$0.63 | -40.12% |
| 2022 | -$1.06 | +6.46% |
| 2021 | -$0.99 | +2.44% |
| 2020 | -$0.97 | -54.25% |
| 2019 | -$2.12 | +43.25% |
| 2018 | -$1.48 | +26.94% |
| 2017 | -$1.17 | -21.49% |
| 2016 | -$1.49 | +19.45% |
| 2015 | -$1.24 | +33.48% |
| 2014 | -$0.93 | N/A |
Comparison Aldeyra Therapeutics (ALDX) five years EPS CAGR with competitors
Aldeyra Therapeutics (ALDX) five years EPS CAGR is -15.26%.